The study ODYSSEY FH I and II with alirokumabem: other pieces in the mosaic of influences inhibition of PCSK9

Abstract

The article describes the course of the study ODYSSEY FH I and II patient population and key findings from studies of FH I and II.

Keywords

• The study ODYSSEY FH I and II
• alirokumab
• PCSK9
• LDL-cholesterol